{"id":24967,"date":"2021-09-27T11:32:38","date_gmt":"2021-09-27T11:32:38","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/es\/?post_type=training-capsules&#038;p=24967"},"modified":"2021-09-27T11:33:58","modified_gmt":"2021-09-27T11:33:58","slug":"jornada-cero-omisiones-cero-alzheimer","status":"publish","type":"training-capsules","link":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer","title":{"rendered":"Jornada \u00abCero Omisiones, Cero Alzheimer\u00bb"},"content":{"rendered":"<p>El 20 de septiembre se celebr\u00f3 la jornada <strong>\u00abCERO OMISIONES, CERO ALZHEIMER\u00bb<\/strong> organizada por la Confederaci\u00f3n Espa\u00f1ola de Alzheimer (CEAFA) y patrocinada por Neuraxpharm.<\/p>\n<p>&nbsp;<\/p>\n<p>La jornada tuvo como tema principal <strong><em>\u201cEl diagn\u00f3stico como base para garantizar la calidad de vida de las personas con demencia\u00bb<\/em><\/strong>,\u00a0 y la apertura fue a cargo de Meritxell Batet, Presidenta del Congreso de los Diputados.<\/p>\n<p>&nbsp;<\/p>\n<p>Neuraxpharm organiz\u00f3 la mesa<span style=\"color: #00b5e2\"> <strong>\u00abEstrategias y avances hacia el diagn\u00f3stico precoz\u00bb<\/strong><\/span> en la que se presentaron los resultados preliminares del estudio <span style=\"color: #00b5e2\"><strong>NeuraxCare<\/strong><\/span>, organizado por Neuraxpharm, cuyo objetivo es analizar la posibilidad de la detecci\u00f3n precoz del deterioro cognitivo en personas mayores en la farmacia comunitaria, a trav\u00e9s de sus cuidadores.<\/p>\n<p>&nbsp;<\/p>\n<p>Desarrollo de la jornada:<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-full wp-image-24963\" src=\"https:\/\/www.neuraxpharm.com\/es\/wp-content\/uploads\/sites\/8\/2021\/09\/21-10007-rrss-ceafa-200921-ng6.jpg\" alt=\"\" width=\"1200\" height=\"1200\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00abEl diagn\u00f3stico como base para mejorar la calidad de vida de las personas con demencia\u00bb Se presentaron los resultados preliminares del estudio NeuraxCare, organizado por Neuraxpharm, cuyo objetivo es analizar la posibilidad de la detecci\u00f3n precoz del deterioro cognitivo en personas mayores en la farmacia comunitaria, a trav\u00e9s de sus cuidadores.<\/p>\n","protected":false},"featured_media":24964,"template":"","categories":[163,158],"languages":[38],"specialties":[],"formats":[29,30],"country":[26],"class_list":["post-24967","training-capsules","type-training-capsules","status-publish","has-post-thumbnail","hentry","categories-alzheimer","categories-demencia","languages-es","formats-online","formats-presencial","country-spain"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Jornada &quot;Cero Omisiones, Cero Alzheimer&quot; - Neuraxpharm Espa\u00f1a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jornada &quot;Cero Omisiones, Cero Alzheimer&quot;\" \/>\n<meta property=\"og:description\" content=\"&quot;El diagn\u00f3stico como base para mejorar la calidad de vida de las personas con demencia&quot; Se presentaron los resultados preliminares del estudio NeuraxCare, organizado por Neuraxpharm, cuyo objetivo es analizar la posibilidad de la detecci\u00f3n precoz del deterioro cognitivo en personas mayores en la farmacia comunitaria, a trav\u00e9s de sus cuidadores.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Espa\u00f1a\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-27T11:33:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1257\" \/>\n\t<meta property=\"og:image:height\" content=\"665\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer\",\"name\":\"Jornada \\\"Cero Omisiones, Cero Alzheimer\\\" - Neuraxpharm Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg\",\"datePublished\":\"2021-09-27T11:32:38+00:00\",\"dateModified\":\"2021-09-27T11:33:58+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer#primaryimage\",\"url\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg\",\"contentUrl\":\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg\",\"width\":1257,\"height\":665},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/\",\"name\":\"Neuraxpharm Espa\u00f1a\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Jornada \"Cero Omisiones, Cero Alzheimer\" - Neuraxpharm Espa\u00f1a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer","og_locale":"es_ES","og_type":"article","og_title":"Jornada \"Cero Omisiones, Cero Alzheimer\"","og_description":"\"El diagn\u00f3stico como base para mejorar la calidad de vida de las personas con demencia\" Se presentaron los resultados preliminares del estudio NeuraxCare, organizado por Neuraxpharm, cuyo objetivo es analizar la posibilidad de la detecci\u00f3n precoz del deterioro cognitivo en personas mayores en la farmacia comunitaria, a trav\u00e9s de sus cuidadores.","og_url":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer","og_site_name":"Neuraxpharm Espa\u00f1a","article_modified_time":"2021-09-27T11:33:58+00:00","og_image":[{"width":1257,"height":665,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer","url":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer","name":"Jornada \"Cero Omisiones, Cero Alzheimer\" - Neuraxpharm Espa\u00f1a","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer#primaryimage"},"thumbnailUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg","datePublished":"2021-09-27T11:32:38+00:00","dateModified":"2021-09-27T11:33:58+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.neuraxpharm.com\/es\/medico\/capsulas-formacion\/jornada-cero-omisiones-cero-alzheimer#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/09\/jornada-ceafa.jpg","width":1257,"height":665},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/es\/#website","url":"https:\/\/www.neuraxpharm.com\/es\/","name":"Neuraxpharm Espa\u00f1a","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/training-capsules\/24967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/training-capsules"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/types\/training-capsules"}],"version-history":[{"count":3,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/training-capsules\/24967\/revisions"}],"predecessor-version":[{"id":24970,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/training-capsules\/24967\/revisions\/24970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media\/24964"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media?parent=24967"}],"wp:term":[{"taxonomy":"categories","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/categories?post=24967"},{"taxonomy":"languages","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/languages?post=24967"},{"taxonomy":"specialties","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/specialties?post=24967"},{"taxonomy":"formats","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/formats?post=24967"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/country?post=24967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}